Rostaing L - Search Results

1

Adherence to and Acceptance of Once-Daily Tacrolimus After Kidney and Liver Transplant: Results From OSIRIS, a French Observational Study.

Cassuto E, Pageaux GP, Cantarovich D, Rostaing L, Loupy A, Roche B, Duvoux C, Moreau K, Thervet E, Mazouz H, Bourhis Y, Dharancy S, Kessler M; OSIRIS investigators. Cassuto E, et al. Among authors: rostaing l. Transplantation. 2016 Oct;100(10):2099-2106. doi: 10.1097/TP.0000000000001307. Transplantation. 2016. PMID: 27653227

2

Course of hemophagocytic histiocytic syndrome in renal transplant patients.

Rostaing L, Fillola G, Baron E, Cisterne JM, Durand D. Rostaing L, et al. Transplantation. 1995 Sep 15;60(5):506-9. doi: 10.1097/00007890-199509000-00018. Transplantation. 1995. PMID: 7676502 No abstract available.

3

Toxoplasmosis in two renal transplant recipients: diagnosis by bone marrow aspiration.

Rostaing L, Baron E, Fillola O, Roques C, Durand D, Massip P, Lloveras JJ, Suc JM. Rostaing L, et al. Transplant Proc. 1995 Apr;27(2):1733-4. Transplant Proc. 1995. PMID: 7725476 No abstract available.

4

Liver B cell lymphoma after liver transplantation.

Rostaing L, Suc B, Fourtanier G, Baron E, Lloveras JJ, Durand D. Rostaing L, et al. Transplant Proc. 1995 Apr;27(2):1781-2. Transplant Proc. 1995. PMID: 7725502 No abstract available.

5

Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients.

Rostaing L, Izopet J, Baron E, Duffaut M, Puel J, Durand D. Rostaing L, et al. Transplantation. 1995 May 27;59(10):1426-31. doi: 10.1097/00007890-199505270-00012. Transplantation. 1995. PMID: 7770930 Clinical Trial.

6

Treatment of chronic hepatitis C with recombinant alpha 2b interferon in kidney transplant recipients: preliminary results and side effects.

Rostaing L, Izopet J, Baron E, Duffaut M, Puel J, Durand D. Rostaing L, et al. Transplant Proc. 1995 Feb;27(1):948-50. Transplant Proc. 1995. PMID: 7879242 Clinical Trial. No abstract available.

7

Comparison between glomerular filtration rate and renal plasma flow between kidney and heart transplant recipients maintained on a similar cyclosporine dosage.

Lloveras JJ, Durand D, Ader JL, Tran Van T, Tack I, Rostaing L, Suc JM. Lloveras JJ, et al. Among authors: rostaing l. Transplant Proc. 1994 Feb;26(1):248. Transplant Proc. 1994. PMID: 8108961 No abstract available.

8

Erythrocytosis after renal transplant: study of erythroid progenitors and response to enalapril.

Rostaing L, Demur C, Huyn A, Durand D, Lloveras JJ, Suc JM. Rostaing L, et al. Transplant Proc. 1994 Feb;26(1):280-1. Transplant Proc. 1994. PMID: 8108980 No abstract available.

9

Clinical outcome of Epstein-Barr viremia in transplant patients.

Rostaing L, Icart J, Durand D, Henry S, Lloveras JJ, Didier J, Suc JM. Rostaing L, et al. Transplant Proc. 1993 Jun;25(3):2286-7. Transplant Proc. 1993. PMID: 8390740 No abstract available.

10

Preliminary results of treatment of chronic hepatitis C with recombinant interferon alpha in renal transplant patients.

Rostaing L, Izopet J, Baron E, Duffaut M, Puel J, Durand D, Suc JM. Rostaing L, et al. Nephrol Dial Transplant. 1995;10 Suppl 6:93-6. doi: 10.1093/ndt/10.supp6.93. Nephrol Dial Transplant. 1995. PMID: 8524507 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

643 results

Search Page